Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction

Several studies showed that hydroxyethyl starch (HES), a synthetic colloid used in volume replacement therapies, interferes with leukocyte-endothelium interactions. Although still unclear, the mechanism seems to involve the inhibition of neutrophils’ integrin. With the aim to provide direc...

Full description

Bibliographic Details
Main Authors: Alessandro Trentini, Francesca Murganti, Valentina Rosta, Carlo Cervellati, Maria Cristina Manfrinato, Savino Spadaro, Franco Dallocchio, Carlo Alberto Volta, Tiziana Bellini
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/20/4/817
id doaj-35fc642fd7d542e884fe7cb2808d4bf4
record_format Article
spelling doaj-35fc642fd7d542e884fe7cb2808d4bf42020-11-25T00:04:18ZengMDPI AGInternational Journal of Molecular Sciences1422-00672019-02-0120481710.3390/ijms20040817ijms20040817Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent InteractionAlessandro Trentini0Francesca Murganti1Valentina Rosta2Carlo Cervellati3Maria Cristina Manfrinato4Savino Spadaro5Franco Dallocchio6Carlo Alberto Volta7Tiziana Bellini8Section of Medical Biochemistry, Molecular Biology and Genetics, Department of Biomedical and Specialist Surgical Sciences, University of Ferrara, 44121 Ferrara, ItalySection of Medical Biochemistry, Molecular Biology and Genetics, Department of Biomedical and Specialist Surgical Sciences, University of Ferrara, 44121 Ferrara, ItalySection of Medical Biochemistry, Molecular Biology and Genetics, Department of Biomedical and Specialist Surgical Sciences, University of Ferrara, 44121 Ferrara, ItalySection of Medical Biochemistry, Molecular Biology and Genetics, Department of Biomedical and Specialist Surgical Sciences, University of Ferrara, 44121 Ferrara, ItalySection of Medical Biochemistry, Molecular Biology and Genetics, Department of Biomedical and Specialist Surgical Sciences, University of Ferrara, 44121 Ferrara, ItalySection of Anesthesia and Intensive Care, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, 44121 Ferrara, ItalySection of Medical Biochemistry, Molecular Biology and Genetics, Department of Biomedical and Specialist Surgical Sciences, University of Ferrara, 44121 Ferrara, ItalySection of Anesthesia and Intensive Care, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, 44121 Ferrara, ItalySection of Medical Biochemistry, Molecular Biology and Genetics, Department of Biomedical and Specialist Surgical Sciences, University of Ferrara, 44121 Ferrara, ItalySeveral studies showed that hydroxyethyl starch (HES), a synthetic colloid used in volume replacement therapies, interferes with leukocyte-endothelium interactions. Although still unclear, the mechanism seems to involve the inhibition of neutrophils&#8217; integrin. With the aim to provide direct evidence of the binding of HES to neutrophils and to investigate the influence of HES on neutrophil chemotaxis, we isolated and treated the cells with different concentrations of fluorescein-conjugated HES (HES-FITC), with or without different stimuli (N-Formylmethionine-leucyl-phenylalanine, fMLP, or IL-8). HES internalization was evaluated by trypan blue quenching and ammonium chloride treatment. Chemotaxis was evaluated by under-agarose assay after pretreatment of the cells with HES or a balanced saline solution. The integrin interacting with HES was identified by using specific blocking antibodies. Our results showed that HES-FITC binds to the plasma membrane of neutrophils without being internalized. Additionally, the cell-associated fluorescence increased after stimulation of neutrophils with fMLP (<i>p</i> &lt; 0.01) but not IL-8. HES treatment impaired the chemotaxis only towards fMLP, event mainly ascribed to the inhibition of CD-11b (Mac-1 integrin) activity. Therefore, the observed effect mediated by HES should be taken into account during volume replacement therapies. Thus, HES treatment could be advantageous in clinical conditions where a low activation/recruitment of neutrophils may be beneficial, but may be harmful when unimpaired immune functions are mandatory.https://www.mdpi.com/1422-0067/20/4/817Hydroxyethyl StarchNeutrophilChemotaxisvolume replacement solutionsfMLPIL-8integrin
collection DOAJ
language English
format Article
sources DOAJ
author Alessandro Trentini
Francesca Murganti
Valentina Rosta
Carlo Cervellati
Maria Cristina Manfrinato
Savino Spadaro
Franco Dallocchio
Carlo Alberto Volta
Tiziana Bellini
spellingShingle Alessandro Trentini
Francesca Murganti
Valentina Rosta
Carlo Cervellati
Maria Cristina Manfrinato
Savino Spadaro
Franco Dallocchio
Carlo Alberto Volta
Tiziana Bellini
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction
International Journal of Molecular Sciences
Hydroxyethyl Starch
Neutrophil
Chemotaxis
volume replacement solutions
fMLP
IL-8
integrin
author_facet Alessandro Trentini
Francesca Murganti
Valentina Rosta
Carlo Cervellati
Maria Cristina Manfrinato
Savino Spadaro
Franco Dallocchio
Carlo Alberto Volta
Tiziana Bellini
author_sort Alessandro Trentini
title Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction
title_short Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction
title_full Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction
title_fullStr Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction
title_full_unstemmed Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction
title_sort hydroxyethyl starch 130/0.4 binds to neutrophils impairing their chemotaxis through a mac-1 dependent interaction
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2019-02-01
description Several studies showed that hydroxyethyl starch (HES), a synthetic colloid used in volume replacement therapies, interferes with leukocyte-endothelium interactions. Although still unclear, the mechanism seems to involve the inhibition of neutrophils&#8217; integrin. With the aim to provide direct evidence of the binding of HES to neutrophils and to investigate the influence of HES on neutrophil chemotaxis, we isolated and treated the cells with different concentrations of fluorescein-conjugated HES (HES-FITC), with or without different stimuli (N-Formylmethionine-leucyl-phenylalanine, fMLP, or IL-8). HES internalization was evaluated by trypan blue quenching and ammonium chloride treatment. Chemotaxis was evaluated by under-agarose assay after pretreatment of the cells with HES or a balanced saline solution. The integrin interacting with HES was identified by using specific blocking antibodies. Our results showed that HES-FITC binds to the plasma membrane of neutrophils without being internalized. Additionally, the cell-associated fluorescence increased after stimulation of neutrophils with fMLP (<i>p</i> &lt; 0.01) but not IL-8. HES treatment impaired the chemotaxis only towards fMLP, event mainly ascribed to the inhibition of CD-11b (Mac-1 integrin) activity. Therefore, the observed effect mediated by HES should be taken into account during volume replacement therapies. Thus, HES treatment could be advantageous in clinical conditions where a low activation/recruitment of neutrophils may be beneficial, but may be harmful when unimpaired immune functions are mandatory.
topic Hydroxyethyl Starch
Neutrophil
Chemotaxis
volume replacement solutions
fMLP
IL-8
integrin
url https://www.mdpi.com/1422-0067/20/4/817
work_keys_str_mv AT alessandrotrentini hydroxyethylstarch13004bindstoneutrophilsimpairingtheirchemotaxisthroughamac1dependentinteraction
AT francescamurganti hydroxyethylstarch13004bindstoneutrophilsimpairingtheirchemotaxisthroughamac1dependentinteraction
AT valentinarosta hydroxyethylstarch13004bindstoneutrophilsimpairingtheirchemotaxisthroughamac1dependentinteraction
AT carlocervellati hydroxyethylstarch13004bindstoneutrophilsimpairingtheirchemotaxisthroughamac1dependentinteraction
AT mariacristinamanfrinato hydroxyethylstarch13004bindstoneutrophilsimpairingtheirchemotaxisthroughamac1dependentinteraction
AT savinospadaro hydroxyethylstarch13004bindstoneutrophilsimpairingtheirchemotaxisthroughamac1dependentinteraction
AT francodallocchio hydroxyethylstarch13004bindstoneutrophilsimpairingtheirchemotaxisthroughamac1dependentinteraction
AT carloalbertovolta hydroxyethylstarch13004bindstoneutrophilsimpairingtheirchemotaxisthroughamac1dependentinteraction
AT tizianabellini hydroxyethylstarch13004bindstoneutrophilsimpairingtheirchemotaxisthroughamac1dependentinteraction
_version_ 1725430191927328768